logo
Food recall 2025: Aldi warns customers to discard these popular items

Food recall 2025: Aldi warns customers to discard these popular items

Time of India09-07-2025
Aldi, a discount supermarket chain, recalls several food items across 37 US states. This action is precautionary. It aims to protect consumers from potential metal contamination and undeclared allergens like peanuts, milk, and soy. Affected products include taquitos, carnitas, salmon, churro bites and vitamin B12. Customers should discard or return these items for a full refund.
Tired of too many ads?
Remove Ads
List of recalled Aldi products in 2025
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Why it matters
Discount supermarket chain Aldi has issued recalls for several food products sold across 37 US states. In coordination with suppliers and federal agencies, the supermarket chain has asked customers to stop using and discard affected products. Aldi says the move is precautionary and aims to protect consumer health. Undeclared allergens , like peanuts, milk, and soy, can pose serious risks to people with allergies. Even trace amounts can cause severe reactions. In some cases, products were also recalled for potential contamination with metal fragments as reported by the Newsweek.Recalled over possible metal contamination. Affected 20-oz boxes (UPC 4061459337471) have best-by dates of 07/03/25 and 09/25/25. Sold in 31 states.Also pulled due to metal contamination. Affected 16-oz trays (UPC 4099100029352) had use-by dates of 06/30/25 and 07/01/25. Sold in 15 states it was recalled on April 21.Recalled on May 27 after undeclared soy was found. Sold in Aldi stores across California, Nevada, and Arizona.Camerican International recalled the product on June 4 due to undeclared milk. It was sold in Aldi stores across 13 states, including Alabama, Florida, and Illinois. No illnesses were reported.RV Pharma recalled the product on June 13 for undeclared peanuts. Sold in 37 states, customers with allergies should avoid it and return for a refund.In an interview with Newsweek, allergy expert Dr. Sebastian Lighvani said that even small amounts of allergens can be dangerous.'An allergic person sees this food as a threat, which triggers an immune response,' he explained. This can lead to inflammation, breathing problems, and even life-threatening reactions in severe cases.Customers are urged to check their pantries and return affected products to Aldi for a full refund. Any unopened or partially used packages should be discarded immediately.Those who feel unwell or suspect an allergic reaction after consuming any of the recalled items should consult a doctor and report the incident to the FDA's MedWatch program.Aldi said in a statement: 'Our top priority is the safety of you and your family. We are committed to high product quality and work with trusted manufacturers to maintain that promise.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Deodorant recall shocker! These everyday brands just failed major safety tests - is your brand on the list?
Deodorant recall shocker! These everyday brands just failed major safety tests - is your brand on the list?

Time of India

time16 hours ago

  • Time of India

Deodorant recall shocker! These everyday brands just failed major safety tests - is your brand on the list?

A company called A.P. Deauville from Pennsylvania is recalling over 67,000 cases of its roll-on deodorants. These deodorants are sold under the Power Stick brand. The recall happened because the products broke important safety rules set by the FDA (U.S. Food and Drug Administration). The safety rules are called Current Good Manufacturing Practices (CGMP), which make sure products are made in a clean and safe way. The recall was officially announced on July 10 by the company, as per the North Jersey report. Explore courses from Top Institutes in Select a Course Category Finance Management MCA Data Analytics Cybersecurity Operations Management Product Management CXO Healthcare Data Science MBA Artificial Intelligence Leadership Data Science Digital Marketing Degree others healthcare PGDM Design Thinking Technology Project Management Others Public Policy Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Fintech & Blockchain India Starts on undefined Get Details The company didn't say exactly what was wrong or what health risks the deodorants could cause. The FDA warned people to stop using these products immediately. You should either throw them away or return them to the store you bought them from, as per the reports. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like New Container Houses Indonesia (Prices May Surprise You) Container House | Search ads Search Now Undo ALSO READ: Navitas stock soars 33% to 52-week high — what's driving the surge in this semiconductor star? Which Deodorants got recalled? Power Stick for Her – Powder Fresh (1.8 oz) UPC: 815195019313 21,265 cases recalled Live Events Power Stick Invisible Protection – Spring Fresh (1.8 oz) UPC: 815195018194 22,482 cases recalled ALSO READ: Paranormal investigator dies after Annabelle doll tour – haunting curse resurfaces in 2025 Power Stick Original Nourishing Invisible Protection (1.8 oz) UPC: 815195018224 23,467 cases recalled These deodorants were sold all over the U.S., including big stores like Walmart and online on Amazon. If you want more info, check the FDA's website or contact the company directly, according to the report by North Jersey. FAQs Q1. Which Power Stick deodorants were recalled in July 2025? Three Power Stick roll-on deodorants were recalled: Powder Fresh, Spring Fresh, and Original Nourishing, all in 1.8 oz size. Q2. Why were Power Stick deodorants recalled by A.P. Deauville? They were recalled for not following FDA's safety manufacturing rules, though exact problems weren't shared.

Popular Power Stick deodorant pulled from Walmart, Amazon shelves in major recall
Popular Power Stick deodorant pulled from Walmart, Amazon shelves in major recall

Mint

time5 days ago

  • Mint

Popular Power Stick deodorant pulled from Walmart, Amazon shelves in major recall

Over 67,000 cases of Power Stick deodorants are being pulled off shelves nationwide after the FDA flagged serious manufacturing problems. A.P. Deauville, the company behind the products, started the recall on July 10 because of violations in factory safety rules, known as "cGMP deviations." While the FDA hasn't detailed exact risks, such issues can mean contamination, unapproved ingredients, or poor quality control. The recalled roll-ons were sold at Walmart, Dollar Tree, and Amazon, putting shoppers across the U.S. at potential risk. If you've bought any Power Stick deodorant recently, stop using it immediately and check if your lot number matches the recall list. The recall targets three specific Power Stick varieties: the "Power Fresh" scent for women, the "Spring Fresh" Invisible Protection line, and the Original Nourishing version. Each comes in a 1.8 oz roll-on bottle. Affected lot numbers include 032026B011 (Power Fresh), 031726A991 (Spring Fresh), and 101225D781 (Original), among dozens of others listed by the FDA. Roughly 21,000–23,000 cases per product are involved, totaling 67,214 cases. The deodorants lack expiration dates, so identifying them relies solely on UPC codes and lot numbers printed on packaging. No injuries have been reported yet, but the FDA stresses that manufacturing flaws could cause skin irritation or infections. Consumers with any recalled Power Stick deodorant should discontinue use right away. To check if your product is unsafe, locate the lot number on the bottom or side of the bottle and match it against the FDA's enforcement report or retailer announcements. If it's on the list, contact Walmart, Dollar Tree, or Amazon for a full refund or replacement. You can also reach out to A.P. Deauville directly through their website for guidance. Even if you've used the product without issues, return it, unseen problems like chemical contamination may still pose hidden dangers. This isn't just about deodorant, it's about trust. A.P. Deauville's Pennsylvania factory claims to be "FDA-regulated," yet it failed basic safety standards designed to protect consumers. Such oversights can lead to nationwide scares, as seen here with products shipped to major discount chains and online giants. The company also makes shampoos, body washes, and facial wipes, though those items aren't part of this recall. The FDA continues investigating, urging public vigilance. Always check recall updates on their website, especially for everyday items applied directly to your skin.

Private Equity infuses ₹4,900 cr in Indian Healthcare with 33 deals in Q2 CY25
Private Equity infuses ₹4,900 cr in Indian Healthcare with 33 deals in Q2 CY25

Time of India

time5 days ago

  • Time of India

Private Equity infuses ₹4,900 cr in Indian Healthcare with 33 deals in Q2 CY25

New Delhi: In the second quarter of calendar year (CY) 2025, in the Indian Healthcare sector global and homegrown private equity firms have deployed a capital of around ₹4,900 crore ($580 million) in 33 deals spanning across Hospitals. Pharma and HealthTech, among others. According to a report from Grant Thornton Bharat, 'in Q2 2025 the Indian Pharma and Healthcare sector recorded a total of 33 PE deals of $580 million.' Against the previous quarter Q2 deal volumes declined by 21 per cent, while values saw a modest 3 per cent uptick—driven by a few mid-sized investments and stands as the second-highest quarter by value since Q2 2024. 'For the quarter PE activity clustered around a few high-confidence, institutional-grade platforms, especially in pharma manufacturing and hospital chains, signalling investor preference for scale, visibility, and IPO readiness,' the report noted. Of the total 33 deals, HealthTech accounted for the highest number with 10 deals, followed by Wellness (7), Pharmaceuticals and Medical Devices (5 each), and Hospitals with 4 deals. Major investments for the period includes US-based General Catalyst 's seed round investment of $218 million (around $18,500 crore) investment in PB Healthcare and Advent International's $175 million investment in Felix Pharma for a 'significant minority stake.' 'In this quarter Pharma and biotech led in value, powered by capital raises and strategic cross-border moves, while hospitals and healthtech platforms continued to evolve along distinct, high-potential growth paths.,' said Bhanu Prakash, Partner and Healthcare Services Industry Leader, Grant Thornton. 'As preventive care and digital health gain ground, we expect sharper, more focused bets in the second half of the year,' he added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store